The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron ...
Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the ...
Here's what makes the daily pill so important ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno, Lilly's group vice president for diabetes and metabolic research ...